What are the Indian guidelines for intravenous immunoglobulin (IVIG) and aspirin dosing in children with Kawasaki disease?

Indian Guidelines for IVIG and Aspirin Dosing in Kawasaki Disease

Unfortunately, there are no specific Indian guidelines provided in the available evidence for IVIG and aspirin dosing in children with Kawasaki disease in the Indian subcontinent. The evidence base consists entirely of American Heart Association guidelines and international research studies.

What You Should Follow

In the absence of India-specific guidelines, apply the 2017 American Heart Association recommendations, which represent the highest quality guideline evidence available 1:

IVIG Dosing

• 2 g/kg as a single infusion over 10-12 hours 1
• Administer within the first 10 days of fever onset
• This dose has demonstrated superior efficacy in meta-analyses compared to lower or divided doses

Aspirin Dosing - Two Acceptable Approaches

Acute Phase:

• US approach: 80-100 mg/kg/day divided every 6 hours 1
• Japanese/European approach: 30-50 mg/kg/day 1

There is no evidence that either aspirin dose is superior to the other for preventing coronary artery abnormalities 1. Recent research even suggests low-dose aspirin from the start may be equally effective 2, 3.

Maintenance Phase:

• Reduce to 3-5 mg/kg/day once afebrile for 48-72 hours 1
• Continue until 6-8 weeks if no coronary abnormalities
• Continue indefinitely if coronary abnormalities develop

Important Caveats for the Subcontinent

Weight Considerations

• The standard 2 g/kg IVIG dose may need adjustment in overweight children to avoid excessive dosing 4
• Consider ideal body weight rather than actual weight in significantly overweight patients

Resource Limitations

• IVIG is expensive and may have limited availability in some settings
• The evidence shows that even a single dose of 1 g/kg (though not standard) was effective in older trials 5
• However, do not compromise on the 2 g/kg dose if at all possible, as this is associated with better outcomes

IVIG Resistance Management

If fever persists ≥36 hours after IVIG completion 1:

• Second dose of IVIG 2 g/kg (Class IIa recommendation)
• Alternative: Methylprednisolone 20-30 mg/kg IV for 3 days (Class IIb)
• Alternative: Infliximab 5 mg/kg (Class IIb)

Clinical Pitfall to Avoid

Do not withhold IVIG in children presenting after day 10 of illness if they have ongoing inflammation (elevated CRP >3.0 mg/dL or ESR) with persistent fever or coronary abnormalities 1. Late treatment is still beneficial.